Literature DB >> 20088952

CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses.

Eike R Hrincius1, Viktor Wixler, Thorsten Wolff, Ralf Wagner, Stephan Ludwig, Christina Ehrhardt.   

Abstract

The non-structural protein 1 (A/NS1) of influenza A viruses (IAV) harbours several src-homology domain (SH) binding motifs that are required for interaction with cellular proteins. The SH3 binding motif at aa212-217 [PPLPPK] of A/NS1 was shown to be essential for binding to the cellular adaptor proteins CRK and CRKL. Both regulate diverse cellular effector pathways, including activation of the MAP-kinase JNK that in turn mediates antiviral responses to IAV infection. By studying functional consequences of A/NS1-CRK interaction we show here that A/NS1 binding to CRK contributes to suppression of the antiviral-acting JNK-ATF2 pathway. However, only IAV that encode an A/NS1-protein harbouring the CRK/CRKL SH3 binding motif PPLPPK were attenuated upon downregulation of CRKI/II and CRKL, but not of CRKII alone. The PPLPPK site-harbouring candidate strains could be discriminated from other strains by a pronounced viral activation of the JNK-ATF2 signalling module that was even further boosted upon knock-down of CRKI/II. Interestingly, this enhanced JNK activation did not alter type-I IFN-expression, but rather resulted in increased levels of virus-induced cell death. Our results imply that binding capacity of A/NS1 to CRK/CRKL has evolved in virus strains that over-induce the antiviral acting JNK-ATF2 signalling module and helps to suppress the detrimental apoptosis promoting action of this pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088952     DOI: 10.1111/j.1462-5822.2010.01436.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  22 in total

1.  Systematic discovery of TLR signaling components delineates viral-sensing circuits.

Authors:  Nicolas Chevrier; Philipp Mertins; Maxim N Artyomov; Alex K Shalek; Matteo Iannacone; Mark F Ciaccio; Irit Gat-Viks; Elena Tonti; Marciela M DeGrace; Karl R Clauser; Manuel Garber; Thomas M Eisenhaure; Nir Yosef; Jacob Robinson; Amy Sutton; Mette S Andersen; David E Root; Ulrich von Andrian; Richard B Jones; Hongkun Park; Steven A Carr; Aviv Regev; Ido Amit; Nir Hacohen
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.

Authors:  Jingting Zhang; Tao Ruan; Tianyu Sheng; Jiongjiong Wang; Jing Sun; Jin Wang; Richard A Prinz; Daxin Peng; Xiufan Liu; Xiulong Xu
Journal:  Virology       Date:  2018-10-10       Impact factor: 3.616

3.  Influenza A Virus Protein NS1 Exhibits Strain-Independent Conformational Plasticity.

Authors:  Sayantan Mitra; Dilip Kumar; Liya Hu; Banumathi Sankaran; Mahdi Muhammad Moosa; Andrew P Rice; Josephine C Ferreon; Allan Chris M Ferreon; B V Venkataram Prasad
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.

Authors:  Anne Sadewasser; Katharina Paki; Katrin Eichelbaum; Boris Bogdanow; Sandra Saenger; Matthias Budt; Markus Lesch; Klaus-Peter Hinz; Andreas Herrmann; Thomas F Meyer; Alexander Karlas; Matthias Selbach; Thorsten Wolff
Journal:  Mol Cell Proteomics       Date:  2017-03-13       Impact factor: 5.911

5.  Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.

Authors:  Wolfgang Nacken; Darisuren Anhlan; Eike R Hrincius; Ahmed Mostafa; Thorsten Wolff; Anne Sadewasser; Stephan Pleschka; Christina Ehrhardt; Stephan Ludwig
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

6.  Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.

Authors:  Thanh H Pham; Xiaofei Gao; Gyanendra Singh; Philip R Hardwidge
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

7.  Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro.

Authors:  Rosaria Santangelo; Cesare Mancuso; Simona Marchetti; Enrico Di Stasio; Giovambattista Pani; Giovanni Fadda
Journal:  Front Pharmacol       Date:  2012-03-09       Impact factor: 5.810

8.  Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 protein.

Authors:  Susana Guerra; Fernando Abaitua; Luis Martínez-Sobrido; Mariano Esteban; Adolfo García-Sastre; Dolores Rodríguez
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

9.  Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.

Authors:  Juliana Del Sarto; Vanessa Gerlt; Yvonne Boergeling; Stephan Ludwig; Marcel Edgar Friedrich; Darisuren Anhlan; Viktor Wixler; Mauro Martins Teixeira
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

10.  Host restrictions of avian influenza viruses: in silico analysis of H13 and H16 specific signatures in the internal proteins.

Authors:  Ragnhild Tønnessen; Anna G Hauge; Elisabeth F Hansen; Espen Rimstad; Christine M Jonassen
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.